Acyclovir Side Effects
Acyclovir is generally well-tolerated, but can cause several side effects ranging from common gastrointestinal disturbances to rare but serious neurological and renal complications. 1
Common Side Effects
Gastrointestinal
- Nausea and vomiting: Occurs in 2.7% of patients on short-term treatment and 4.8% on long-term administration 1
- Diarrhea: Reported in 2.4-3.2% of patients on various treatment regimens 1
- Gastrointestinal distress 1
General
Serious Side Effects
Renal
Neurological
- Neurotoxicity: Usually occurs within 24-48 hours of therapy initiation 2
- More common in elderly, those with renal impairment, or patients on nephrotoxic drugs 2
- Symptoms include: confusion, hallucinations, agitation, seizures, tremors, ataxia, dysarthria, encephalopathy, decreased consciousness, delirium, psychosis, somnolence 1, 2
- Particularly marked in older adults and patients with renal impairment 1
- Reversible after therapy withdrawal 2
Other Serious Reactions
- Hypersensitivity reactions: Anaphylaxis, angioedema 1
- Hematologic: Anemia, leukopenia, thrombocytopenia, leukocytoclastic vasculitis 1
- Hepatic: Elevated liver function tests, hepatitis, jaundice 1
- Dermatologic: Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme 1
Special Populations
Pregnancy
- Classified as Category B in FDA pregnancy rating 3
- Registry data on 596 infants exposed to acyclovir during first trimester showed birth defect rates similar to general population 3
- Not routinely recommended during pregnancy except for serious infections 3
Immunocompromised Patients
- May experience more severe side effects 3
- Higher doses often needed, increasing risk of adverse effects 3
- Risk of acyclovir-resistant strains with persistent lesions during treatment 3
Overdose Considerations
- Can lead to agitation, coma, seizures, lethargy 1
- Precipitation in renal tubules when solubility (2.5 mg/mL) is exceeded 1
- Hemodialysis may be beneficial in acute renal failure 1
Risk Mitigation
- Maintain adequate hydration to reduce risk of nephropathy 3
- Monitor renal function, especially with IV therapy 3
- Adjust dosage in patients with pre-existing renal impairment 4
- Discontinue immediately if neurological symptoms develop 2
- Consider hemodialysis for severe toxicity or overdose 1
Monitoring Recommendations
- Regular assessment of renal function during treatment
- Close observation for neurological symptoms, particularly in high-risk patients
- Prompt evaluation of any mental status changes during therapy 2
Acyclovir's safety profile is generally favorable compared to its antiviral benefits 5, but clinicians should remain vigilant for the development of serious adverse effects, particularly in high-risk populations.